End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.4 PLN | +20.00% | +30.29% | +128.00% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 17.48 | 24.43 | 29.79 | 21.91 | 10.95 | 27.52 |
Enterprise Value (EV) 1 | 37.78 | 32.23 | 36.66 | 20.28 | 22.29 | 33.04 |
P/E ratio | -4.32 x | -4.31 x | -5.59 x | -1.6 x | -10.2 x | 3.7 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.18 x | 0.24 x | 0.29 x | 0.22 x | 0.11 x | 0.25 x |
EV / Revenue | 0.38 x | 0.32 x | 0.36 x | 0.2 x | 0.22 x | 0.3 x |
EV / EBITDA | 23.7 x | 68.6 x | -23.6 x | -4.59 x | -5.95 x | 14.2 x |
EV / FCF | -48.1 x | 3.64 x | 21.9 x | -8.14 x | -10.5 x | 124 x |
FCF Yield | -2.08% | 27.5% | 4.58% | -12.3% | -9.49% | 0.8% |
Price to Book | 2.62 x | 3.42 x | 4.87 x | 2.66 x | -3.46 x | 9 x |
Nbr of stocks (in thousands) | 4,482 | 4,482 | 4,884 | 5,504 | 5,504 | 5,504 |
Reference price 2 | 3.900 | 5.450 | 6.100 | 3.980 | 1.990 | 5.000 |
Announcement Date | 05/04/19 | 07/04/20 | 23/04/21 | 21/03/22 | 31/03/23 | 05/04/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 98.22 | 100 | 102.7 | 100.3 | 102.9 | 109.9 |
EBITDA 1 | 1.592 | 0.4697 | -1.551 | -4.42 | -3.746 | 2.32 |
EBIT 1 | -1.538 | -2.515 | -4.931 | -7.753 | -5.801 | 0.528 |
Operating Margin | -1.57% | -2.51% | -4.8% | -7.73% | -5.64% | 0.48% |
Earnings before Tax (EBT) 1 | -3.903 | -5.725 | -5.224 | -13.62 | -1.073 | 8.122 |
Net income 1 | -4.048 | -5.672 | -5.331 | -13.65 | -1.078 | 7.432 |
Net margin | -4.12% | -5.67% | -5.19% | -13.61% | -1.05% | 6.76% |
EPS 2 | -0.9030 | -1.266 | -1.092 | -2.480 | -0.1959 | 1.350 |
Free Cash Flow 1 | -0.7856 | 8.858 | 1.678 | -2.491 | -2.116 | 0.2655 |
FCF margin | -0.8% | 8.86% | 1.63% | -2.48% | -2.06% | 0.24% |
FCF Conversion (EBITDA) | - | 1,885.73% | - | - | - | 11.44% |
FCF Conversion (Net income) | - | - | - | - | - | 3.57% |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 05/04/19 | 07/04/20 | 23/04/21 | 21/03/22 | 31/03/23 | 05/04/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 20.3 | 7.81 | 6.87 | - | 11.3 | 5.52 |
Net Cash position 1 | - | - | - | 1.63 | - | - |
Leverage (Debt/EBITDA) | 12.75 x | 16.62 x | -4.427 x | - | -3.026 x | 2.381 x |
Free Cash Flow 1 | -0.79 | 8.86 | 1.68 | -2.49 | -2.12 | 0.27 |
ROE (net income / shareholders' equity) | -46.5% | -78.4% | -75.1% | -186% | -42.5% | -13,501% |
ROA (Net income/ Total Assets) | -1.99% | -3.25% | -6.44% | -10.1% | -8.72% | 1.03% |
Assets 1 | 203.8 | 174.5 | 82.75 | 135 | 12.37 | 723.6 |
Book Value Per Share 2 | 1.490 | 1.590 | 1.250 | 1.500 | -0.5800 | 0.5600 |
Cash Flow per Share 2 | 0.7300 | 1.100 | 0.6800 | 0.8200 | 0.5500 | 0.5700 |
Capex 1 | 3.06 | 4.1 | 1.85 | 1.17 | 0.49 | 0.48 |
Capex / Sales | 3.12% | 4.1% | 1.8% | 1.17% | 0.47% | 0.43% |
Announcement Date | 05/04/19 | 07/04/20 | 23/04/21 | 21/03/22 | 31/03/23 | 05/04/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+128.00% | 16.01M | |
-9.85% | 38.7B | |
+14.40% | 36.58B | |
+8.55% | 33.85B | |
+0.34% | 18.54B | |
+1.18% | 14.54B | |
-10.94% | 14.02B | |
+22.11% | 12.42B | |
-0.36% | 12.42B | |
-.--% | 11.82B |
- Stock Market
- Equities
- ORG Stock
- Financials ORGANIC Farma Zdrowia S.A.